Bill Sponsor
House Bill 124
117th Congress(2021-2022)
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021
Introduced
Introduced
Introduced in House on Jan 4, 2021
Overview
Text
Sponsor
Introduced
Jan 4, 2021
Latest Action
Feb 2, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
124
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Texas
Democrat
District of Columbia
Republican
Kentucky
Democrat
Mississippi
Republican
Nebraska
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2021

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Text (1)
January 4, 2021
Actions (3)
02/02/2021
Referred to the Subcommittee on Health.
01/04/2021
Referred to the House Committee on Energy and Commerce.
01/04/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:43:42 PM